Agios Pharmaceuticals | AGIO - Market Capitalization


Agios Pharmaceuticals reported $1.72B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Agios Pharmaceuticals USD 1.6B 16M Feb/2026
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
Arrowhead Research USD 8.04B 973M Feb/2026
Astellas Pharma JPY 4.33T 546.23B Feb/2026
AstraZeneca USD 222.33B 65.82B Feb/2026
Bayer EUR 27.23B 2.14B Sep/2025
Biogen USD 27.01B 1.19B Feb/2026
BioMarin Pharmaceutical USD 11.99B 575M Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 1.01T 3.37B Feb/2026
Exelixis USD 12.27B 523M Feb/2026
Gilead Sciences USD 183.59B 31.31B Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Incyte USD 22.7B 3.31B Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Merck USD 300.37B 39.11B Feb/2026
Moderna USD 16.5B 6.41B Feb/2026
Nektar Therapeutics USD 113M 4M Sep/2023
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 303.91B 57.84B Feb/2026
Pfizer USD 152.89B 11.32B Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026